The peroxisome proliferator-activated receptor-gamma has been the focus of intense research during the past decade because ligands for this receptor have emerged as potent insulin sensitizers used in the treatment of type II diabetes. This evidence concerns the gene PPARG and type 2 diabetes mellitus.